For example, differential methylation of Sept9 in patient blood is used for diagnosis of colorectal cancer [65,66] and detection of the non-coding RNA PCA3 in patient urine is used for risk assessment of prostate cancer [67-70]. This evidence concerns the gene SEPTIN9 and colorectal cancer.